| [1] |
Mo M, Liu GY, Lv LL, et al. Advances in breast cancer screening program[J]. Zhong Liu, 2012, 32(9): 748-54. [莫淼, 柳光宇, 吕力琅, 等. 乳腺癌筛查研究进展[J]. 肿瘤, 2012, 32(9): 748-54.]
|
| [2] |
Bundred NJ. Prognostic and predictive factors in breast cancer[J]. Cancer Treat Rev, 2001, 27(3): 137-42.
|
| [3] |
Fisher B. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century[J]. Eur J Cancer, 1999, 35(14): 1963-73.
|
| [4] |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J]. Int J Cancer, 2010, 12 7(12): 2893-917.
|
| [5] |
Smetherman DH. Screening, imaging, and image-guided biopsy techniques for breast cancer[J]. Surg Clin North Am, 2013, 93(2): 30 9-27.
|
| [6] |
Huang XQ, Zeng H. Correlation between gene expression profiles of adenocarcinoma of esophagus and Barrett's esophagus[J]. Zhong Liu Fang Zhi Yan Jiu, 2009, 36(8): 639-42. [黄绪群, 曾辉. 食管腺癌与Barrett’s食管基因表达谱的研究[J]. 肿瘤防治研究, 20 09, 36(8): 639-42.]
|
| [7] |
Kuasela P, Haglund C, Ruberts PJ. Comparison of a new tumour marker CA242 with CA19-9, CA50 and carcinoembryonic antigen (CEA) in digestive tract disease[J]. Br J Cancer, 1991, 63 (4) : 636-40.
|
| [8] |
Chinese Society of Laboratory Medicine, National Center for Clinical Laboratories, Editorial Committee of Chinese Journal of Laboratory Medicine. Advice of tumor markers in clinical application[J]. Zhonghua Jian Yan Yi Xue Za Zhi, 2012, 35(2): 10 3-16. [中华医学会检验分会, 卫生部临床检验中心, 中华检 验医学杂志编辑委员会.肿瘤标志物的临床应用建议[J]. 中华 检验医学杂志, 2012, 35(2): 103-16.]
|
| [9] |
Sha L, Cao Y, Shi L. Usefulness of tumor markers CA153, CA125, CEA and AFP in early diagnosis of breast tumor by ROC curve[J]. Guo Ji Jian Yan Yi Xue Za Zhi, 2007, 28(11): 1039-40. [沙玲, 曹 研, 施莉. 应用ROC曲线对肿瘤标志物CA153、CA125、CEA 和AFP在乳腺肿瘤早期诊断中的应用价值评价[J]. 国际检验医 学杂志, 2007, 28(11): 1039-40.]
|
| [10] |
Zhang H, Xiang MJ, Mao SL, et al. The clinical value of the combined measurement of three serum tumor markers in breast cancer[J]. Zhongguo Shi Yan Zhen Duan Xue, 2011, 15(1): 96-8. [张华, 项明洁, 毛顺露, 等. 三项肿瘤标志物联合检测在乳腺癌 诊断中的价值[J]. 中国实验诊断学, 2011, 15(1): 96-8.]
|
| [11] |
Shen Q, Song GH, Zhang JX, et al. Comprehensive evaluation of the diagnostic value of contrast-enhanced sonography for breast cancer by ROC curve and logistic regression[J]. Shi Yong Yi Xue Za Zhi, 2009, 25(7): 1058-60. [沈嫱, 宋光辉, 张建兴, 等. Logistic回归及ROC曲线综合评价超声造影对乳腺癌的诊断 [J] 实用医学杂志, 2009, 25(7): 1058-60.]
|
| [12] |
Karn T, Metzler D, Ruckhäberle E, et al. Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer[J]. Breast Cancer Res Treat, 2010, 12 0(3): 567-79.
|
| [13] |
Rody A, Karn T, Ruckhäberle E, et al. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer[J]. Breast Cancer Res Treat, 2009, 113(3): 457-66.
|
| [14] |
Tilanus-Linthorst M, Verhoog L, Obdeijn IM, et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography[J]. Int J Cancer, 2002, 102(1): 91-5.
|
| [15] |
Hong X, Zhang YQ. Progress on JAK-STAT signaling pathway in cancer research[J]. Ji Chu Yi Xue Yu Lin Chuang, 2011, 31(4): 46 3-6. [洪璇, 张艳桥. JAK-STAT信号传导通路在肿瘤中的进 展[J] 基础医学与临床, 2011, 31(4): 463-6.]
|
| [16] |
Zeng L. Progress on MARK signaling pathway in invasion and metastasis of tumor[J]. Zhong Liu Fang Zhi Yan Jiu, 2002, 29(5): 91 4-6. [曾亮. MAPK信号通路与肿瘤侵袭和转移研究进展[J]. 肿瘤防治研究, 2002, 29(5): 914-6.]
|
| [17] |
Xie BC, Li GL. Wnt gene/Wnt signaling pathway in breast cancer[J]. Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao, 2011, 27(2): 125-9. [谢碧琛, 李国利. Wnt基因/Wnt 通路与乳腺癌[J]. 中国生物化学与分子生物学报, 2011, 27(2): 12 5-9.]
|
下载:
